Showing results (891-900 of 6,488) with videos related to
Sort By:
Pageof 649
Journal of Thrombosis and Haemostasis : JTH|October 26, 2005
Expression studies on a novel type 2B variant of the von Willebrand factor gene (R1308L) characterized by defective collagen bindingL Baronciani, A B Federici, M Beretta, et al.Journal of Thrombosis and Haemostasis : JTH|October 26, 2005
Comparison of cell-surface TFPIalpha and betaO Piro, G J BrozeJournal of Thrombosis and Haemostasis : JTH|October 26, 2005
Helical computed tomography and alternative diagnosis in patients with excluded pulmonary embolismM J L van Strijen, J L Bloem, W de Monyé, et al.Journal of Thrombosis and Haemostasis : JTH|October 26, 2005
BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging studyA G G Turpie, W D Fisher, K A Bauer, et al.Journal of Thrombosis and Haemostasis : JTH|October 26, 2005
A novel polymorphism in the factor XIII B-subunit (His95Arg): relationship to subunit dissociation and venous thrombosisN Komanasin, A J Catto, T S Futers, et al.Journal of Thrombosis and Haemostasis : JTH|December 1, 2009
Multiple electrode aggregometry predicts stent thrombosis better than the vasodilator-stimulated phosphoprotein phosphorylation assayJ M Siller-Matula, G Christ, I M Lang, et al.Journal of Thrombosis and Haemostasis : JTH|June 15, 2025
Identification of phenotypes in thrombotic primary antiphospholipid syndrome using cluster analysis: a step toward personalized medicineGabrielle M Santos, Paula David, Or Hen, et al.Journal of Thrombosis and Haemostasis : JTH|July 18, 2025
Mathematical analysis of emicizumab: affinity-driven complex formation and lipid-surface reactionsJamie Madrigal, Dougald M Monroe, Suzanne S Sindi, et al.Journal of Thrombosis and Haemostasis : JTH|July 13, 2025
Effects of milvexian alone or with heparin on catheter-induced clotting and thrombin generationRuiqi Yin, James C Fredenburgh, Jeffrey I WeitzJournal of Thrombosis and Haemostasis : JTH|June 8, 2025
DOAC-Stop reverses the anticoagulant effect of asundexian and milvexianElla K Fitzpatrick, James C Fredenburgh, Jeffrey I WeitzPageof 649